Smith IE - Search Results

1

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas.

Ellis PA, Lonning PE, Borresen-Dale A, Aas T, Geisler S, Akslen LA, Salter I, Smith IE, Dowsett M. Ellis PA, et al. Among authors: smith ie. Br J Cancer. 1997;76(4):480-5. doi: 10.1038/bjc.1997.413. Br J Cancer. 1997. PMID: 9275025 Free PMC article.

2

Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.

Johnston SR, Saccani-Jotti G, Smith IE, Salter J, Newby J, Coppen M, Ebbs SR, Dowsett M. Johnston SR, et al. Among authors: smith ie. Cancer Res. 1995 Aug 1;55(15):3331-8. Cancer Res. 1995. PMID: 7614468

3

Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: validation against ligand-binding assay and clinical relevance in breast cancer.

Newby JC, A'Hern RP, Leek RD, Smith IE, Harris AL, Dowsett M. Newby JC, et al. Among authors: smith ie. Br J Cancer. 1995 Jun;71(6):1237-42. doi: 10.1038/bjc.1995.239. Br J Cancer. 1995. PMID: 7779717 Free PMC article.

4

Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.

Ellis PA, Makris A, Burton SA, Titley J, Ormerod MG, Salter J, Powles TJ, Smith IE, Dowsett M. Ellis PA, et al. Among authors: smith ie. Br J Cancer. 1996 Mar;73(5):640-3. doi: 10.1038/bjc.1996.111. Br J Cancer. 1996. PMID: 8605100 Free PMC article.

5

The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance.

Johnston SR, Riddler S, Haynes BP, A'Hern R, Smith IE, Jarman M, Dowsett M. Johnston SR, et al. Among authors: smith ie. Br J Cancer. 1997;75(6):804-9. doi: 10.1038/bjc.1997.144. Br J Cancer. 1997. PMID: 9062399 Free PMC article.

6

Primary chemotherapy for early breast cancer.

Ellis PA, Smith IE. Ellis PA, et al. Among authors: smith ie. Cancer Treat Rev. 1996 Nov;22(6):437-50. doi: 10.1016/s0305-7372(96)90025-0. Cancer Treat Rev. 1996. PMID: 9134004 Review.

7

Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy.

Ellis PA, Smith IE, Detre S, Burton SA, Salter J, A'Hern R, Walsh G, Johnston SR, Dowsett M. Ellis PA, et al. Among authors: smith ie. Breast Cancer Res Treat. 1998 Mar;48(2):107-16. doi: 10.1023/a:1005933815809. Breast Cancer Res Treat. 1998. PMID: 9596482

8

Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer.

Archer CD, Parton M, Smith IE, Ellis PA, Salter J, Ashley S, Gui G, Sacks N, Ebbs SR, Allum W, Nasiri N, Dowsett M. Archer CD, et al. Among authors: smith ie. Br J Cancer. 2003 Sep 15;89(6):1035-41. doi: 10.1038/sj.bjc.6601173. Br J Cancer. 2003. PMID: 12966422 Free PMC article.

9

Towards a molecular basis for tamoxifen resistance in breast cancer.

Johnston SR, Dowsett M, Smith IE. Johnston SR, et al. Among authors: smith ie. Ann Oncol. 1992 Jul;3(7):503-11. doi: 10.1093/oxfordjournals.annonc.a058251. Ann Oncol. 1992. PMID: 1498070 Free article. Review.

10

A dose-comparative endocrine-clinical study of leuprorelin in premenopausal breast cancer patients.

Dowsett M, Mehta A, Mansi J, Smith IE. Dowsett M, et al. Among authors: smith ie. Br J Cancer. 1990 Nov;62(5):834-7. doi: 10.1038/bjc.1990.388. Br J Cancer. 1990. PMID: 2123115 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

516 results

Search Page

Filters